Hepatology • Portal Hypertension

Hepatic Encephalopathy Explained: Ammonia, Portosystemic Shunting and Brain Dysfunction

Hepatic encephalopathy is a reversible brain dysfunction caused by liver failure and/or portosystemic shunting. When the liver cannot adequately detoxify substances such as ammonia, neurotoxins accumulate and impair brain function, producing symptoms that range from subtle concentration difficulties to coma.

Dr. Seneth Gajasinghe, MBBS, MD Published: 10 June 2026 Updated: 10 June 2026 20 min read Reviewed Content

Most students know that ammonia causes hepatic encephalopathy.

Few understand why ammonia rises, why TIPS worsens it, why GI bleeding triggers it, and why lactulose works.

Hepatic encephalopathy is the neurological complication that ties together portal hypertension, variceal bleeding, SBP and TIPS into a single coherent story. Understanding hepatic encephalopathy requires understanding the liver's detoxification role — and what happens when that role fails.

Where HE Sits in the Portal Hypertension Cluster

Portal hypertension → ascites → SBP → HRS
Portal hypertension → varices → variceal bleeding
Portal hypertension → TIPS → hepatic encephalopathy
Cirrhosis itself → impaired detoxification → hepatic encephalopathy

Learning Objectives

  • Define hepatic encephalopathy and explain why it is a brain problem caused by liver disease
  • Explain the role of ammonia and how the healthy liver removes it
  • Understand how portosystemic shunting contributes to HE
  • Describe the West Haven classification (Grades 0–4)
  • Identify common precipitating factors and explain why each triggers HE
  • Explain the specific mechanisms by which GI bleeding and SBP trigger HE
  • Explain why TIPS increases the risk of hepatic encephalopathy
  • Understand how lactulose and rifaximin reduce ammonia and treat HE
  • Distinguish minimal HE from overt HE

What Is Hepatic Encephalopathy?

Hepatic encephalopathy (HE) is a potentially reversible neuropsychiatric syndrome caused by liver dysfunction and/or portosystemic shunting.

It occurs when the liver fails to remove neurotoxic substances — most importantly ammonia — from the circulation. These toxins accumulate and impair brain function, producing a spectrum of neurological and psychiatric disturbances.

Core Concept

HE is a brain problem caused by liver disease. The damaged organ is the liver; the organ that malfunctions is the brain. The bridge between the two is failure of hepatic detoxification — particularly of ammonia.

HE can occur in two settings:

  • Acute liver failure — sudden severe loss of liver function (e.g. paracetamol overdose, acute viral hepatitis)
  • Cirrhosis and chronic liver disease — either episodic (triggered by a precipitant) or persistent (ongoing impairment in advanced disease)

This article focuses primarily on HE in cirrhosis, which is the most commonly encountered setting in clinical practice and examinations.

Normal Ammonia Detoxification

To understand why ammonia accumulates in liver disease, you must first understand where ammonia comes from and how the healthy body removes it.

Where Does Ammonia Come From?

Ammonia is produced continuously in the gut by two main mechanisms:

  • Bacterial metabolism — colonic bacteria break down undigested proteins and urea, releasing ammonia as a byproduct
  • Amino acid deamination — dietary protein digestion releases ammonia during amino acid breakdown in the gut and elsewhere

How Is It Normally Removed?

Ammonia absorbed from the gut enters the portal vein and travels directly to the liver. In the healthy liver, hepatocytes convert ammonia to urea via the urea cycle. Urea is then excreted in the urine. This first-pass hepatic detoxification is highly efficient — almost all ammonia is removed before it can reach the systemic circulation and the brain.

Gut bacteria + protein digestion ↓ Ammonia produced ↓ Portal vein ↓ Healthy liver → urea cycle ↓ Ammonia converted to urea ↓ Excreted safely in urine
Diagram showing normal ammonia detoxification pathway: gut bacteria produce ammonia which enters the portal vein and is converted to urea by the healthy liver via the urea cycle before safe urinary excretion
Figure 1. Normal ammonia detoxification. Ammonia produced in the gut enters the portal vein and is converted to urea by the liver, protecting the brain from toxic ammonia levels.

Where Does Ammonia Come From?

Ammonia is not produced only from dietary protein. Several sources contribute to the ammonia load reaching the portal circulation.

SourceHow It Increases Ammonia
Dietary proteinProtein digestion produces amino acids; bacterial metabolism generates ammonia.
Gut bacteriaUrease-producing bacteria break down urea and nitrogenous substrates into ammonia.
GI bleedingBlood in the gut acts as a large protein load and sharply increases ammonia production.
ConstipationProlonged stool retention gives bacteria more time to produce and release ammonia.
Muscle breakdownCatabolism increases nitrogen load and ammonia generation.
Renal dysfunctionReduced ammonia excretion contributes to systemic accumulation.
Infographic showing sources of ammonia in hepatic encephalopathy including dietary protein gut bacteria GI bleeding constipation muscle breakdown and renal dysfunction
Figure 2. Sources of ammonia in hepatic encephalopathy. Gut-derived ammonia is the main source, but bleeding, constipation, catabolism and renal dysfunction can all increase ammonia burden.

Pathophysiology of Hepatic Encephalopathy

In cirrhosis, two processes combine to allow ammonia and other toxins to reach the brain in dangerous concentrations.

ProblemMechanismEffect
Impaired hepatic detoxificationCirrhotic hepatocytes have reduced urea cycle capacityLess ammonia converted to urea — blood ammonia rises
Portosystemic shuntingCollateral vessels and TIPS bypass the liverPortal blood (containing ammonia) reaches systemic circulation without detoxification

Once in the systemic circulation, ammonia crosses the blood-brain barrier. Within the brain, astrocytes — the cells responsible for much of the brain's own ammonia detoxification via glutamine synthesis — swell in response to the ammonia load. This astrocyte swelling is thought to be a central mechanism causing cerebral oedema and brain dysfunction in HE.

Cirrhosis ↓ ↓ Detoxification + portosystemic shunting ↓ Ammonia ↑ in systemic blood ↓ Crosses blood-brain barrier ↓ Astrocyte swelling ↓ Brain dysfunction → HE
Beyond Ammonia

Ammonia is the most important neurotoxin in HE, but not the only one. Inflammatory cytokines, mercaptans, short-chain fatty acids and GABA-receptor modulating substances also contribute. This explains why ammonia levels do not always correlate perfectly with clinical HE severity — multiple toxins are involved.

Pathophysiology diagram of hepatic encephalopathy showing cirrhosis impairing liver detoxification and portosystemic shunting allowing ammonia to reach the systemic circulation cross the blood-brain barrier and cause astrocyte swelling and brain dysfunction
Figure 4. Pathophysiology of hepatic encephalopathy. Impaired detoxification and portosystemic shunting together allow ammonia and other neurotoxins to reach the brain in damaging concentrations.

Ammonia Levels in Hepatic Encephalopathy

Ammonia is central to the pathophysiology of hepatic encephalopathy, but ammonia level alone does not diagnose HE.

HE is a clinical diagnosis. Ammonia measurement can support the diagnosis, but it must be interpreted in the clinical context.

Ammonia ResultInterpretation
Normal ammoniaMakes hepatic encephalopathy less likely, but does not fully exclude it.
Elevated ammonia with confusionSupports HE if the patient has liver disease or portosystemic shunting.
Elevated ammonia without symptomsDoes not prove HE. Some patients with cirrhosis have elevated ammonia without obvious encephalopathy.
Very high ammoniaMay suggest severe toxin burden, but clinical grade still depends on neurological assessment.
Exam Pearl

Do not diagnose hepatic encephalopathy from ammonia alone. The diagnosis requires compatible clinical features in a patient with liver disease or portosystemic shunting.

Infographic explaining how to interpret ammonia levels in hepatic encephalopathy including normal ammonia elevated ammonia symptomatic patients and asymptomatic hyperammonemia
Figure 3. Ammonia level interpretation in hepatic encephalopathy. Ammonia supports the diagnosis, but HE remains a clinical diagnosis.

Role of Portosystemic Shunting

Portosystemic shunting is the second critical mechanism in HE and explains several important clinical scenarios — including why TIPS dramatically increases encephalopathy risk.

In portal hypertension, elevated portal pressure opens alternative venous channels (portosystemic collaterals) that allow portal blood to reach the systemic circulation without passing through the liver. The most important sites are the distal esophagus, stomach, rectum and umbilicus — but any portosystemic collateral contributes to this bypass.

Two Routes to the Brain

Route 1 — Impaired detoxification: Portal blood enters the liver but hepatocytes cannot adequately convert ammonia to urea.
Route 2 — Shunting: Portal blood bypasses the liver entirely via collaterals or TIPS, delivering undetoxified ammonia directly to the systemic circulation.

This is why HE worsens in several clinical scenarios: when TIPS is placed (creating a deliberate large portosystemic shunt), when portal hypertension worsens (opening more collaterals), or when liver function deteriorates further (reducing residual detoxification capacity).

Diagram comparing normal portal circulation where the liver detoxifies ammonia against portosystemic shunting where portal blood bypasses the liver via collaterals or TIPS delivering undetoxified ammonia to the systemic circulation and brain
Figure 5. Portosystemic shunting and hepatic encephalopathy. When portal blood bypasses the liver — via natural collaterals or TIPS — ammonia reaches the systemic circulation and brain without detoxification.

Clinical Features

Hepatic encephalopathy produces a spectrum of neuropsychiatric disturbances that reflect the degree of toxic impairment of brain function. Symptoms tend to fluctuate and are often worse in the evening or at night.

Progression of Features

As ammonia and neurotoxin burden increases, clinical features progress:

  • Subtle impairment — reduced concentration, slowed thought, minor personality change
  • Sleep disturbance — reversal of sleep-wake cycle (drowsy by day, wakeful at night)
  • Confusion and disorientation — to time, then place, then person
  • Lethargy and drowsiness — progressive reduction in conscious level
  • Coma — no response to stimuli in severe cases
Asterixis — The Flapping Tremor

Asterixis is the characteristic physical sign of hepatic encephalopathy. It is demonstrated by asking the patient to extend their arms and dorsiflex their wrists ("stop traffic" position). Brief, intermittent lapses of sustained posture cause the wrists to momentarily flap downward before returning to position. This "flapping tremor" reflects failure of sustained motor control caused by ammonia and neurotoxin impairment of the thalamic reticular system. Asterixis is typically present in Grade 2 HE. It is not specific to HE — it also occurs in uraemia, hypercapnia and other metabolic encephalopathies.

West Haven Classification

The West Haven criteria grade hepatic encephalopathy from 0 to 4 based on neuropsychiatric features. This grading system is the most widely used in clinical practice and examinations.

Grade 0
Minimal HE — Normal clinical examination; subtle cognitive impairment detectable only on psychometric or neurophysiological testing. Sometimes called covert HE.
Grade 1
Mild confusion — Mild cognitive impairment, reduced concentration, sleep-wake reversal, mild euphoria or anxiety. Clinical signs may be subtle.
Grade 2
Lethargy — Obvious disorientation to time, asterixis, lethargy, inappropriate behaviour, slurred speech.
Grade 3
Marked confusion — Gross disorientation, somnolence but arousable, marked confusion, incomprehensible speech.
Grade 4
Coma — Unresponsive to verbal or painful stimuli.
Exam Pearl

Grades 1–2 are sometimes called overt HE (clinically apparent); Grade 0 is minimal or covert HE (detectable only on testing). Grades 3–4 represent severe HE requiring intensive management. Grade 4 = coma — this is a consistently tested fact.

Visual grading chart showing the West Haven classification of hepatic encephalopathy from Grade 0 minimal covert HE through Grade 1 mild confusion Grade 2 lethargy and asterixis Grade 3 marked confusion to Grade 4 coma
Figure 6. West Haven classification of hepatic encephalopathy. The spectrum ranges from clinically imperceptible minimal HE (Grade 0) to coma (Grade 4).

Covert vs Overt Hepatic Encephalopathy

Hepatic encephalopathy is often divided into covert HE and overt HE. This distinction is useful because early HE may not be obvious during routine clinical examination.

FeatureCovert HEOvert HE
West Haven gradeGrade 0 and sometimes Grade 1Usually Grades 2–4
Clinical visibilitySubtle or not obvious on routine examinationClinically obvious confusion, asterixis or altered consciousness
DetectionPsychometric or neurophysiological testing may be neededClinical diagnosis
Functional impactDriving impairment, reduced attention, reduced work performanceHospital admission, falls, aspiration risk, coma risk
Exam clueNormal-looking patient with impaired testingCirrhosis + confusion + asterixis
Key Idea

Covert HE affects function even when the patient looks clinically normal. Overt HE is clinically apparent and usually needs active treatment and precipitant search.

What Triggers Hepatic Encephalopathy?

In most patients with cirrhosis, an acute episode of HE has an identifiable precipitating factor. Identifying and correcting the trigger is the cornerstone of acute management.

TriggerMechanism
GI bleedingBlood in the gut is a large protein load — bacterial digestion produces a surge of ammonia
Infection (including SBP)Systemic inflammation impairs brain tolerance to ammonia and other toxins
ConstipationProlonged gut transit increases ammonia absorption from the colon
DehydrationReduces renal ammonia clearance; worsens circulatory dysfunction
HypokalaemiaAlters renal ammonia handling — increased renal ammoniagenesis
Sedatives and opioidsDirect CNS depression compounds neurotoxin-driven impairment
Excess protein intakeIncreases substrate for ammonia production in the gut
TIPS placementCreates large portosystemic shunt — portal blood bypasses liver detoxification
Hepatocellular carcinomaProgressive loss of functional liver mass reduces detoxification capacity
Exam Tip

The most commonly examined triggers are GI bleeding, infection/SBP, constipation and TIPS. Know the mechanism for each — especially why GI bleeding and SBP precipitate HE, as these have specific mechanistic explanations.

Summary diagram of common precipitating factors for hepatic encephalopathy including GI bleeding infection SBP constipation dehydration hypokalaemia sedatives excess protein and TIPS with their mechanisms
Figure 7. Precipitating factors for hepatic encephalopathy. Each increases the ammonia burden or reduces the brain's tolerance to existing toxin levels.

Why Does GI Bleeding Trigger Hepatic Encephalopathy?

Gastrointestinal bleeding is one of the most important precipitants of HE in cirrhosis. Understanding the mechanism explains why certain treatments (antibiotic prophylaxis, lactulose) are given routinely in this setting.

Blood enters gut lumen ↓ Haemoglobin and proteins digested by bacteria ↓ Large surge in ammonia production ↓ Absorbed into portal circulation ↓ Overwhelms impaired liver detoxification ↓ Blood ammonia rises ↓ HE precipitated

Blood is essentially a very large protein load in the gut. When 500 mL of blood enters the gut from a variceal bleed, the nitrogen content can be equivalent to a large protein meal. Gut bacteria metabolise this protein to ammonia far faster than the cirrhotic liver can clear it.

Why Antibiotics Are Routine in GI Bleeding

In variceal bleeding, antibiotic prophylaxis is mandatory — not only to prevent SBP, but also because reducing gut bacterial activity decreases ammonia production from the blood protein load, reducing the risk of precipitating HE.

Why Does SBP Trigger Hepatic Encephalopathy?

Spontaneous bacterial peritonitis is one of the most important precipitants of HE, and it frequently presents with HE as the primary neurological manifestation — sometimes before fever or abdominal pain are apparent.

SBP — peritoneal infection ↓ Systemic inflammatory response ↓ Pro-inflammatory cytokines ↓ Impair blood-brain barrier function ↓ Brain more vulnerable to existing ammonia levels ↓ HE precipitated or worsened
Clinical Importance

In a cirrhotic patient presenting with confusion, always consider SBP. HE may be the presenting feature of SBP even when fever and abdominal pain are absent. A diagnostic ascitic tap should be performed urgently in any cirrhotic patient with new or worsening HE.

Why Does TIPS Increase Hepatic Encephalopathy Risk?

TIPS creates a deliberate, large portosystemic shunt between the portal vein and hepatic vein. This is its mechanism of benefit — and also its most important complication.

TIPS placed ↓ Portal blood diverts through stent ↓ Bypasses liver entirely ↓ Ammonia + toxins enter systemic circulation undetoxified ↓ Higher brain toxin exposure ↓ HE risk rises
The Trade-Off

The same mechanism that makes TIPS effective also causes its most important complication. TIPS reduces portal pressure by bypassing the liver — but this reduces hepatic detoxification. It is why pre-existing hepatic encephalopathy is a relative contraindication to TIPS, and why patients are monitored closely for HE after TIPS placement.

Diagram showing how TIPS creates a direct portal-to-systemic shunt that bypasses liver detoxification allowing ammonia to reach the brain in higher concentrations and increasing the risk of hepatic encephalopathy
Figure 8. TIPS and hepatic encephalopathy. By diverting portal blood away from the liver, TIPS reduces portal pressure but simultaneously increases the ammonia and neurotoxin load delivered to the brain.

How Is Hepatic Encephalopathy Treated?

The management of acute HE follows a four-step framework. All steps are applied simultaneously, not sequentially.

  • 1Identify the precipitant. Review for GI bleeding, infection (including SBP), constipation, dehydration, hypokalaemia, sedatives, dietary excess protein. Most episodes have an identifiable trigger.
  • 2Correct the precipitant. Treat infection with antibiotics, control GI bleeding, correct electrolytes, stop sedatives, relieve constipation. Correcting the trigger often resolves the HE without further treatment.
  • 3Reduce ammonia. Lactulose is the first-line agent for reducing intestinal ammonia. Titrate to 2–3 soft bowel motions per day. Rifaximin is added for recurrent or refractory HE.
  • 4Prevent recurrence. Ongoing lactulose and rifaximin for secondary prophylaxis. Address modifiable risk factors — optimise nutrition, avoid sedatives, monitor for new triggers.
Key Principle

HE is often reversible when the precipitant is identified and corrected promptly. The metabolic encephalopathy itself tends to improve as the ammonia burden falls. This reversibility distinguishes HE from structural brain disease.

Lactulose Explained

Lactulose is a non-absorbable synthetic disaccharide and the first-line treatment for hepatic encephalopathy. Its mechanism directly targets the gut source of ammonia.

How Lactulose Works

Lactulose is not absorbed in the small intestine. It reaches the colon intact, where gut bacteria metabolise it to produce lactic and acetic acids. These acids lower the colonic pH. The acidic environment converts ammonia (NH₃) — a gas that crosses the colonic wall readily — into ammonium (NH₄⁺), an ionised form that cannot be absorbed. Ammonium remains trapped in the colon and is excreted in stool.

Lactulose ingested ↓ Reaches colon unabsorbed ↓ Bacteria produce lactic + acetic acid ↓ Colonic pH falls (acidification) ↓ NH₃ + H⁺ → NH₄⁺ (ammonium) ↓ Ammonium cannot be absorbed ↓ Excreted in stool → ammonia ↓

Lactulose also acts as an osmotic laxative, drawing water into the colon and accelerating gut transit. This reduces the time available for ammonia production and absorption.

Practical Pearl

The treatment goal is 2–3 soft bowel motions per day. Under-dosing leaves too much ammonia in the gut; over-dosing causes diarrhoea, dehydration and electrolyte disturbance — which can worsen HE. Dose titration to bowel frequency is important.

Diagram showing lactulose mechanism in hepatic encephalopathy: lactulose acidifies the colon converting ammonia NH3 to ammonium NH4 plus which is trapped in stool and excreted reducing blood ammonia and HE
Figure 9. Lactulose mechanism. Colonic acidification by lactulose converts absorbable ammonia (NH₃) into non-absorbable ammonium (NH₄⁺), trapping it in stool and reducing blood ammonia.

Rifaximin Explained

Rifaximin is a non-absorbable oral antibiotic that works at a different point in the ammonia pathway compared to lactulose. Rather than trapping produced ammonia, rifaximin reduces the bacterial populations responsible for producing it in the first place.

Rifaximin acts in gut ↓ Reduces ammonia-producing bacteria ↓ Less ammonia produced from protein ↓ Lower ammonia absorbed into portal blood ↓ HE recurrence risk ↓
Rifaximin vs Lactulose

Lactulose — traps ammonia after it is produced (acidification).
Rifaximin — reduces ammonia production by targeting the bacteria that make it.
The two mechanisms are complementary. Rifaximin is primarily used for secondary prophylaxis — preventing recurrent overt HE in patients who have already had an episode — usually in combination with lactulose.

Diagram showing rifaximin mechanism in hepatic encephalopathy: rifaximin acts locally in the gut reducing urease-producing bacteria which decreases ammonia generation from protein digestion and lowers systemic ammonia
Figure 10. Rifaximin mechanism. By reducing ammonia-producing gut bacteria, rifaximin decreases the amount of ammonia generated, complementing the trapping effect of lactulose.

Minimal Hepatic Encephalopathy

Minimal HE (West Haven Grade 0 / covert HE) is present in up to 30–40% of patients with cirrhosis. It is not detectable on standard clinical examination but significantly impairs quality of life, cognitive function and safety.

FeatureDetails
Clinical examinationNormal — no asterixis, no confusion detectable on routine assessment
Psychometric testsAbnormal — impaired attention, reaction time, visuospatial ability
DrivingReduced driving performance and increased accident risk
Work performanceReduced concentration and productivity
Quality of lifeSignificantly impaired despite appearing clinically normal
Progression riskPredicts future overt HE episodes
Driving and Minimal HE

Patients with minimal HE have impaired reaction times and decision-making that compromises safe driving, even when they appear neurologically normal on examination. This is an important counselling point for patients with cirrhosis, particularly those with known prior HE episodes.

Severity, Recurrence and Prognosis

A single episode of hepatic encephalopathy may be fully reversible, especially when the precipitating factor is identified early and corrected. However, recurrent HE is clinically important because it reflects advanced liver disease and reduced physiological reserve.

Single HE episode ↓ Often reversible ↓ Recurrent HE ↓ Poor quality of life ↓ Marker of decompensated cirrhosis ↓ Consider transplant assessment

Recurrent HE is associated with hospital admissions, falls, driving impairment, caregiver burden and reduced survival. It should prompt review of liver disease severity, precipitating factors, nutritional status and transplant suitability.

Link to MELD and Child-Pugh

Hepatic encephalopathy is part of the Child-Pugh score and is a marker of decompensated cirrhosis. MELD helps quantify transplant priority using objective laboratory values, while Child-Pugh captures clinical decompensation including ascites and encephalopathy.

HE vs Delirium vs Dementia

In clinical practice, distinguishing hepatic encephalopathy from other causes of acute or chronic cognitive impairment is important — particularly in patients where the diagnosis of cirrhosis is not yet established.

FeatureHepatic EncephalopathyDeliriumDementia
Liver diseaseYes — essential for diagnosisVariable — any systemic causeNo
OnsetAcute or subacute; episodicAcuteInsidious, progressive
ReversibilityOften reversible with treatmentOften reversible when cause treatedUsually irreversible
AsterixisCommon (Grade 2)RareRare
AmmoniaOften elevatedNormal (unless HE is cause)Normal
FluctuationYes — worse at nightYes — worse at nightGradual worsening over months/years
Key Differentiator

The combination of liver disease + acute/fluctuating confusion + asterixis strongly suggests HE rather than primary delirium or dementia. However, patients with cirrhosis can also develop delirium from other causes — always identify the precipitant rather than assuming all confusion is HE.

One-Minute Hepatic Encephalopathy Revision

Cirrhosis + portosystemic shunting ↓ Ammonia bypasses liver detoxification ↓ Ammonia ↑ in blood → crosses blood-brain barrier ↓ Astrocyte swelling → brain dysfunction ↓ Hepatic encephalopathy (Grades 0–4) ↓ Triggers: GI bleed / SBP / constipation / TIPS ↓ Treatment: correct trigger + lactulose + rifaximin
One-minute revision summary of hepatic encephalopathy showing cirrhosis and portosystemic shunting causing ammonia to reach the brain leading to HE Grades 0 to 4 with common triggers and treatment including lactulose and rifaximin
Figure 11. One-minute hepatic encephalopathy revision: from cirrhosis and impaired detoxification through ammonia accumulation, grading and treatment.

High-Yield Exam Pearls

Quick Memory Pattern

Most important toxin = ammonia
Most important physical sign = asterixis (Grade 2)
Most common precipitant = infection
Grade 4 = coma
Lactulose = traps ammonia (acidification: NH₃ → NH₄⁺)
Rifaximin = reduces bacterial ammonia production
GI bleed → protein load → ammonia surge → HE
SBP → inflammation → brain more sensitive to toxins
TIPS → portal blood bypasses liver → HE risk ↑
HE is often reversible

Exam Tips — Hepatic Encephalopathy
  • Always look for a trigger — most acute HE episodes have an identifiable precipitant; finding and treating it is the priority.
  • SBP presents as HE — in a cirrhotic patient with confusion, always consider SBP and perform a diagnostic tap even if abdominal symptoms are absent.
  • GI bleeding mechanism — blood is a large protein load in the gut; bacterial digestion releases a surge of ammonia that overwhelms the impaired liver.
  • Lactulose mechanism — acidification of colon converts NH₃ (absorbable) to NH₄⁺ (non-absorbable, excreted in stool). Goal: 2–3 soft stools/day.
  • Rifaximin is for secondary prophylaxis — not first-line for acute HE; used to prevent recurrence in patients who have already had overt HE.
  • TIPS and HE — the mechanism is the same as for natural portosystemic shunting: portal blood bypasses liver detoxification. This is why pre-existing HE is a relative contraindication to TIPS.
  • Ammonia vs clinical grade — ammonia does not always correlate with HE severity. HE is a clinical diagnosis; ammonia supports it but should not be used alone.
  • Minimal HE — clinically silent but impairs driving ability and quality of life. Detectable only on psychometric testing.
  • HE is clinical — ammonia supports the diagnosis but does not define severity or prove HE alone.
  • Covert HE — may look normal on routine examination but affects driving, attention and work performance.
  • Overt HE — clinically obvious HE, especially West Haven Grade 2 or above.
  • Protein restriction — avoid prolonged severe restriction; malnutrition and sarcopenia worsen ammonia handling.
  • Recurrent HE — suggests advanced decompensated cirrhosis and should prompt transplant-oriented thinking.

Key Takeaways

  • Hepatic encephalopathy is a reversible neuropsychiatric syndrome caused by liver failure and/or portosystemic shunting
  • The liver normally converts ammonia to urea via the urea cycle — in cirrhosis, this process fails
  • Two mechanisms combine: impaired hepatic detoxification and portosystemic shunting that bypasses the liver
  • Ammonia crosses the blood-brain barrier, causes astrocyte swelling, and impairs brain function
  • Ammonia supports the diagnosis of HE, but HE remains a clinical diagnosis
  • Elevated ammonia without symptoms does not prove hepatic encephalopathy
  • Covert HE may impair driving and attention despite a normal routine examination
  • Overt HE is clinically apparent and usually corresponds to West Haven Grades 2–4
  • Recurrent HE is a marker of decompensated cirrhosis and should prompt specialist review and transplant consideration where appropriate
  • Long-term severe protein restriction is usually avoided because malnutrition and sarcopenia can worsen outcomes
  • West Haven grades: 0 = minimal (covert), 1 = mild confusion, 2 = lethargy + asterixis, 3 = marked confusion, 4 = coma
  • Asterixis (flapping tremor) is the characteristic physical sign — typically present at Grade 2
  • Common precipitants: GI bleeding, infection/SBP, constipation, dehydration, hypokalaemia, sedatives, TIPS
  • GI bleeding triggers HE by providing a large protein load for bacterial ammonia production
  • SBP triggers HE via systemic inflammation that increases brain sensitivity to existing toxin levels
  • TIPS increases HE risk because portal blood bypasses hepatic detoxification via the stent
  • Lactulose acidifies the colon, converting NH₃ to NH₄⁺ — reducing ammonia absorption. Goal: 2–3 soft stools/day
  • Rifaximin reduces ammonia-producing gut bacteria — used for secondary prophylaxis of recurrent HE
  • Minimal HE is clinically silent but impairs driving performance and quality of life
  • HE is often reversible when the precipitant is identified and corrected promptly

Frequently Asked Questions

What causes hepatic encephalopathy?+
Hepatic encephalopathy is caused by the accumulation of neurotoxic substances — most importantly ammonia — that reach the brain when the liver fails to remove them adequately. In cirrhosis, two problems combine: impaired hepatic detoxification means the urea cycle cannot keep pace with ammonia production; and portosystemic shunting allows portal blood to bypass the liver entirely, delivering ammonia and other toxins directly to the systemic circulation without detoxification. The combination of both mechanisms is what drives most episodes of HE in cirrhosis.
Is ammonia always elevated in hepatic encephalopathy?+
No. Ammonia levels do not reliably correlate with the presence or severity of HE. Some patients have elevated ammonia without encephalopathy; others have significant HE with only modestly elevated ammonia. This is because HE is a clinical diagnosis based on neuropsychiatric features, not a biochemical one. Multiple toxins beyond ammonia contribute — including inflammatory cytokines, mercaptans and GABA-receptor modulators. Ammonia measurement can support the diagnosis and guide treatment, but it should not be used in isolation.
What is asterixis?+
Asterixis is the characteristic physical sign of hepatic encephalopathy — often called a "flapping tremor." It is demonstrated by asking the patient to extend their arms and dorsiflex their wrists. Brief, intermittent lapses of sustained posture cause the hands to momentarily drop before returning to position. This reflects failure of sustained motor control caused by ammonia and neurotoxin impairment of thalamic and brainstem function. Asterixis is typically present in Grade 2 HE. It is not specific to liver disease — it also occurs in uraemia, respiratory failure and other metabolic encephalopathies.
What is the West Haven classification?+
The West Haven classification grades hepatic encephalopathy from 0 to 4 based on clinical features. Grade 0 (minimal HE) has no clinical signs but subtle cognitive impairment on testing. Grade 1 shows mild confusion and sleep reversal. Grade 2 shows lethargy, disorientation and asterixis. Grade 3 shows marked confusion and somnolence. Grade 4 is coma. The system is useful for clinical communication and guiding management, but individual assessments can be difficult because symptoms fluctuate. Grades 1–4 are termed overt HE; Grade 0 is covert or minimal HE.
Why does GI bleeding trigger hepatic encephalopathy?+
Gastrointestinal bleeding delivers a large protein load to the gut lumen. Blood contains haemoglobin and other proteins that gut bacteria metabolise to ammonia as a byproduct. A significant variceal bleed can deliver the nitrogen equivalent of a large protein meal into the intestine very rapidly. This causes a surge in ammonia production and absorption that overwhelms the already-impaired liver's detoxification capacity, causing blood ammonia to rise and precipitating or worsening encephalopathy. This is why antibiotic prophylaxis and lactulose are given routinely in cirrhotic patients presenting with GI bleeding.
Why does constipation trigger hepatic encephalopathy?+
Constipation prolongs the time gut contents remain in the colon, giving colonic bacteria more time to metabolise nitrogen-containing substrates — from undigested dietary protein, shed intestinal cells and recycled urea — into ammonia. More ammonia is then absorbed from the colon into the portal circulation. In a patient with cirrhosis and impaired hepatic detoxification, even a modest increment in ammonia production and absorption can tip the balance and precipitate or worsen encephalopathy. This is one reason lactulose — which accelerates gut transit and reduces ammonia absorption — is the cornerstone of HE management.
Why does TIPS increase hepatic encephalopathy risk?+
TIPS creates a direct stent channel between the portal vein and hepatic vein, allowing portal blood to bypass the liver. Before TIPS, even in cirrhosis, a proportion of portal blood passes through functioning hepatocytes where partial detoxification of ammonia occurs. After TIPS, this first-pass hepatic detoxification is significantly reduced because portal blood flows directly into the systemic circulation via the shunt without entering liver tissue. Higher concentrations of ammonia and other neurotoxins reach the brain, increasing the risk of encephalopathy. This is the primary trade-off of TIPS and is why pre-existing encephalopathy is a relative contraindication.
How does lactulose work in hepatic encephalopathy?+
Lactulose is a non-absorbable disaccharide that reduces ammonia absorption from the colon by two mechanisms. First, colonic bacteria metabolise lactulose to produce lactic and acetic acids, lowering the colonic pH. This acidic environment converts ammonia (NH₃) — which is readily absorbed through the colonic wall — into ammonium (NH₄⁺), which is ionised and cannot cross the mucosal barrier. Ammonium is then trapped in stool and excreted. Second, lactulose acts as an osmotic laxative, accelerating bowel transit and reducing the time available for ammonia production and absorption. The goal is 2–3 soft bowel motions daily; over-dosing causes diarrhoea and worsens dehydration.
How does rifaximin work in hepatic encephalopathy?+
Rifaximin is a non-absorbable oral antibiotic that acts locally in the gastrointestinal tract. It reduces the population of urease-producing and other ammonia-generating gut bacteria, decreasing the amount of ammonia generated from dietary protein and other nitrogen sources. Unlike lactulose, which traps produced ammonia, rifaximin reduces its production. The two mechanisms are complementary and the drugs are often used together. Rifaximin is primarily used for secondary prophylaxis — preventing recurrent overt HE episodes in patients who have already had one — rather than for acute treatment alone.
Can hepatic encephalopathy be reversed?+
In most cases, yes. Hepatic encephalopathy is defined as a potentially reversible condition — and many episodes do resolve with appropriate treatment, particularly when a precipitant is identified and corrected. Patients who were confused or comatose can recover to their neurological baseline once ammonia levels fall. However, recovery depends on the severity and reversibility of the underlying liver disease. Patients with very advanced cirrhosis may have a reduced baseline after repeated episodes, and prolonged or severe HE may be associated with persistent cognitive impairment. Liver transplantation can fully reverse HE by restoring normal hepatic detoxification.
Can a patient with hepatic encephalopathy recover completely?+
Yes, many patients recover completely from an acute episode of hepatic encephalopathy, especially when the precipitating factor is found and corrected early. For example, HE triggered by constipation, infection, dehydration or GI bleeding may improve significantly after treating the trigger and reducing ammonia with lactulose or rifaximin. However, recurrent HE usually indicates advanced cirrhosis and may leave patients with reduced baseline cognition, poor quality of life and increased risk of future episodes. Recurrent or severe HE should prompt specialist review and consideration of transplant suitability where appropriate.
What foods should be avoided in hepatic encephalopathy?+
Modern management does not recommend severe long-term protein restriction for most patients with cirrhosis, because malnutrition and muscle wasting can worsen outcomes and reduce ammonia handling by muscle. During severe acute HE, temporary adjustment of protein intake may be needed under medical supervision, but long-term care usually focuses on adequate nutrition, vegetable and dairy protein sources when appropriate, avoiding constipation, and treating triggers. Alcohol should be avoided in alcohol-related liver disease. Dietary advice should be individualised by the treating team or dietitian.
Is hepatic encephalopathy the same as dementia?+
No. Hepatic encephalopathy is usually an acute or fluctuating metabolic brain dysfunction caused by liver disease or portosystemic shunting. It is often reversible when the trigger is corrected and ammonia is reduced. Dementia is usually a chronic progressive neurodegenerative condition. However, recurrent HE can cause persistent cognitive impairment and may mimic dementia in some patients. The clinical context is essential: liver disease, fluctuating confusion, asterixis and precipitating factors suggest HE rather than primary dementia.

References

  1. Vilstrup H, Amodio P, Bajaj J, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014;60(2):715–735.
  2. European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406–460.
  3. Bass NM, Mullen KD, Sanyal A, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med. 2010;362(12):1071–1081.
  4. Sharma BC, Sharma P, Agrawal A, Sarin SK. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo. Gastroenterology. 2009;137(3):885–891.
  5. Prakash R, Mullen KD. Mechanisms, diagnosis and management of hepatic encephalopathy. Nat Rev Gastroenterol Hepatol. 2010;7(9):515–525.
  6. Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy — definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna 1998. Hepatology. 2002;35(3):716–721.
Medical Education Disclaimer

This article is intended for medical education only. It is designed for medical students, intern doctors, and junior doctors and does not constitute clinical advice. Always refer to current local guidelines and specialist hepatological input when managing patients with hepatic encephalopathy.

In This Article
Author
SG
Dr. Seneth Gajasinghe
MBBS, MD
Medical Reviewer
Reviewed Content
Reviewed before publication
Subjects
Hepatology Neurology Portal Hypertension Clinical Medicine
Related Articles
Portal Hypertension Explained TIPS Explained Variceal Bleeding Explained SBP Explained Ascites Explained Hepatorenal Syndrome Explained Child-Pugh Score Explained MELD Score Explained
Hepatology Articles Submit Your Article